Monday, May 20, 2024
Facebook Linkedin Twitter
HomeTagsAtopic Dermatitis

Atopic Dermatitis

Biotechnology

Brexogen’s Exosome Therapy for Atopic Dermatitis, ‘BRE-AD01’ Accepted for Phase 1 Clinical Trials

PR Newswire -
The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based therapy for atopic dermatitis. 'BRE-AD01' is being...
Biotechnology

Hoth Therapeutics Announces HREC Approval in Australia for the Next Phase of its Trial of BioLexa for Patients with Atopic Dermatitis

PR Newswire -
Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced it has received approval by the Bellberry Human Research Ethics Committee (HREC) in Australia to initiate...
Biotechnology

Amytrx Therapeutic’s AMTX-100 CF3 Moves to Phase II Clinical Trial for Atopic Dermatitis

PR Newswire -
Amytrx and Amarex Clinical Research, LLC, an NSF company, announced they are initiating the Phase II clinical trial on atopic dermatitis (AD) using Amytrx's...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us